0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Extracellular Vesicles Based Liquid Biopsy Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-34S16761
Home | Market Reports | Health| Nursing
Global Extracellular Vesicles Based Liquid Biopsy Market Research Report 2024
BUY CHAPTERS

Global Extracellular Vesicles Based Liquid Biopsy Market Research Report 2026

Code: QYRE-Auto-34S16761
Report
2026-04-10
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Extracellular Vesicles Based Liquid Biopsy Market

The global Extracellular Vesicles Based Liquid Biopsy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Extracellular Vesicles Based Liquid Biopsy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Extracellular Vesicles Based Liquid Biopsy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Extracellular Vesicles Based Liquid Biopsy in Therapeutic Monitoring is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Extracellular Vesicles Based Liquid Biopsy include Bio-Techne, Thermo Fisher Scientific, Qiagen, Exosome Diagnostics, Aethlon Medical, System Biosciences, NanoSomix, Norgen Biotek, Hitachi Chemical, Lonza Group, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Extracellular Vesicles Based Liquid Biopsy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracellular Vesicles Based Liquid Biopsy. The Extracellular Vesicles Based Liquid Biopsy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Extracellular Vesicles Based Liquid Biopsy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Extracellular Vesicles Based Liquid Biopsy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Extracellular Vesicles Based Liquid Biopsy Market Report

Report Metric Details
Report Name Extracellular Vesicles Based Liquid Biopsy Market
Segment by Type
  • Blood-derived Liquid Biopsy
  • Urine-derived Liquid Biopsy
  • Saliva-derived Liquid Biopsy
  • Other
Segment by Application
  • Therapeutic Monitoring
  • Medical Diagnostics
  • Biological Research
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio-Techne, Thermo Fisher Scientific, Qiagen, Exosome Diagnostics, Aethlon Medical, System Biosciences, NanoSomix, Norgen Biotek, Hitachi Chemical, Lonza Group, Stemcell Technologies, Aruna Bio, Evomic Science, Izon Science, Exovita Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Extracellular Vesicles Based Liquid Biopsy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Extracellular Vesicles Based Liquid Biopsy Market report?

Ans: The main players in the Extracellular Vesicles Based Liquid Biopsy Market are Bio-Techne, Thermo Fisher Scientific, Qiagen, Exosome Diagnostics, Aethlon Medical, System Biosciences, NanoSomix, Norgen Biotek, Hitachi Chemical, Lonza Group, Stemcell Technologies, Aruna Bio, Evomic Science, Izon Science, Exovita Biosciences

What are the Application segmentation covered in the Extracellular Vesicles Based Liquid Biopsy Market report?

Ans: The Applications covered in the Extracellular Vesicles Based Liquid Biopsy Market report are Therapeutic Monitoring, Medical Diagnostics, Biological Research, Other

What are the Type segmentation covered in the Extracellular Vesicles Based Liquid Biopsy Market report?

Ans: The Types covered in the Extracellular Vesicles Based Liquid Biopsy Market report are Blood-derived Liquid Biopsy, Urine-derived Liquid Biopsy, Saliva-derived Liquid Biopsy, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Blood-derived Liquid Biopsy
1.2.3 Urine-derived Liquid Biopsy
1.2.4 Saliva-derived Liquid Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Extracellular Vesicles Based Liquid Biopsy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Therapeutic Monitoring
1.3.3 Medical Diagnostics
1.3.4 Biological Research
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Perspective (2021–2032)
2.2 Global Extracellular Vesicles Based Liquid Biopsy Growth Trends by Region
2.2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Region (2021–2026)
2.2.3 Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Region (2027–2032)
2.3 Extracellular Vesicles Based Liquid Biopsy Market Dynamics
2.3.1 Extracellular Vesicles Based Liquid Biopsy Industry Trends
2.3.2 Extracellular Vesicles Based Liquid Biopsy Market Drivers
2.3.3 Extracellular Vesicles Based Liquid Biopsy Market Challenges
2.3.4 Extracellular Vesicles Based Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracellular Vesicles Based Liquid Biopsy Players by Revenue
3.1.1 Global Top Extracellular Vesicles Based Liquid Biopsy Players by Revenue (2021–2026)
3.1.2 Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Players (2021–2026)
3.2 Global Top Extracellular Vesicles Based Liquid Biopsy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Extracellular Vesicles Based Liquid Biopsy Revenue
3.4 Global Extracellular Vesicles Based Liquid Biopsy Market Concentration Ratio
3.4.1 Global Extracellular Vesicles Based Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracellular Vesicles Based Liquid Biopsy Revenue in 2025
3.5 Global Key Players of Extracellular Vesicles Based Liquid Biopsy Head Offices and Areas Served
3.6 Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Products and Applications
3.7 Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Extracellular Vesicles Based Liquid Biopsy Breakdown Data by Type
4.1 Global Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Type (2021–2026)
4.2 Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Type (2027–2032)
5 Extracellular Vesicles Based Liquid Biopsy Breakdown Data by Application
5.1 Global Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Application (2021–2026)
5.2 Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
6.2 North America Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2021–2026)
6.4 North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
7.2 Europe Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2021–2026)
7.4 Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
8.2 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2021–2026)
8.4 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
9.2 Latin America Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2021–2026)
9.4 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
10.2 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2021–2026)
10.4 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne
11.1.1 Bio-Techne Company Details
11.1.2 Bio-Techne Business Overview
11.1.3 Bio-Techne Extracellular Vesicles Based Liquid Biopsy Introduction
11.1.4 Bio-Techne Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.1.5 Bio-Techne Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Extracellular Vesicles Based Liquid Biopsy Introduction
11.2.4 Thermo Fisher Scientific Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Extracellular Vesicles Based Liquid Biopsy Introduction
11.3.4 Qiagen Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.3.5 Qiagen Recent Development
11.4 Exosome Diagnostics
11.4.1 Exosome Diagnostics Company Details
11.4.2 Exosome Diagnostics Business Overview
11.4.3 Exosome Diagnostics Extracellular Vesicles Based Liquid Biopsy Introduction
11.4.4 Exosome Diagnostics Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.4.5 Exosome Diagnostics Recent Development
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Details
11.5.2 Aethlon Medical Business Overview
11.5.3 Aethlon Medical Extracellular Vesicles Based Liquid Biopsy Introduction
11.5.4 Aethlon Medical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.5.5 Aethlon Medical Recent Development
11.6 System Biosciences
11.6.1 System Biosciences Company Details
11.6.2 System Biosciences Business Overview
11.6.3 System Biosciences Extracellular Vesicles Based Liquid Biopsy Introduction
11.6.4 System Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.6.5 System Biosciences Recent Development
11.7 NanoSomix
11.7.1 NanoSomix Company Details
11.7.2 NanoSomix Business Overview
11.7.3 NanoSomix Extracellular Vesicles Based Liquid Biopsy Introduction
11.7.4 NanoSomix Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.7.5 NanoSomix Recent Development
11.8 Norgen Biotek
11.8.1 Norgen Biotek Company Details
11.8.2 Norgen Biotek Business Overview
11.8.3 Norgen Biotek Extracellular Vesicles Based Liquid Biopsy Introduction
11.8.4 Norgen Biotek Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.8.5 Norgen Biotek Recent Development
11.9 Hitachi Chemical
11.9.1 Hitachi Chemical Company Details
11.9.2 Hitachi Chemical Business Overview
11.9.3 Hitachi Chemical Extracellular Vesicles Based Liquid Biopsy Introduction
11.9.4 Hitachi Chemical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.9.5 Hitachi Chemical Recent Development
11.10 Lonza Group
11.10.1 Lonza Group Company Details
11.10.2 Lonza Group Business Overview
11.10.3 Lonza Group Extracellular Vesicles Based Liquid Biopsy Introduction
11.10.4 Lonza Group Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.10.5 Lonza Group Recent Development
11.11 Stemcell Technologies
11.11.1 Stemcell Technologies Company Details
11.11.2 Stemcell Technologies Business Overview
11.11.3 Stemcell Technologies Extracellular Vesicles Based Liquid Biopsy Introduction
11.11.4 Stemcell Technologies Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.11.5 Stemcell Technologies Recent Development
11.12 Aruna Bio
11.12.1 Aruna Bio Company Details
11.12.2 Aruna Bio Business Overview
11.12.3 Aruna Bio Extracellular Vesicles Based Liquid Biopsy Introduction
11.12.4 Aruna Bio Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.12.5 Aruna Bio Recent Development
11.13 Evomic Science
11.13.1 Evomic Science Company Details
11.13.2 Evomic Science Business Overview
11.13.3 Evomic Science Extracellular Vesicles Based Liquid Biopsy Introduction
11.13.4 Evomic Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.13.5 Evomic Science Recent Development
11.14 Izon Science
11.14.1 Izon Science Company Details
11.14.2 Izon Science Business Overview
11.14.3 Izon Science Extracellular Vesicles Based Liquid Biopsy Introduction
11.14.4 Izon Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.14.5 Izon Science Recent Development
11.15 Exovita Biosciences
11.15.1 Exovita Biosciences Company Details
11.15.2 Exovita Biosciences Business Overview
11.15.3 Exovita Biosciences Extracellular Vesicles Based Liquid Biopsy Introduction
11.15.4 Exovita Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.15.5 Exovita Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Blood-derived Liquid Biopsy
 Table 3. Key Players of Urine-derived Liquid Biopsy
 Table 4. Key Players of Saliva-derived Liquid Biopsy
 Table 5. Key Players of Other
 Table 6. Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2021–2026)
 Table 10. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2027–2032)
 Table 12. Extracellular Vesicles Based Liquid Biopsy Market Trends
 Table 13. Extracellular Vesicles Based Liquid Biopsy Market Drivers
 Table 14. Extracellular Vesicles Based Liquid Biopsy Market Challenges
 Table 15. Extracellular Vesicles Based Liquid Biopsy Market Restraints
 Table 16. Global Extracellular Vesicles Based Liquid Biopsy Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Players (2021–2026)
 Table 18. Global Top Extracellular Vesicles Based Liquid Biopsy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Extracellular Vesicles Based Liquid Biopsy Revenue, 2025
 Table 19. Ranking of Global Top Extracellular Vesicles Based Liquid Biopsy Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Extracellular Vesicles Based Liquid Biopsy Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Headquarters and Area Served
 Table 22. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Products and Applications
 Table 23. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Type (2021–2026)
 Table 27. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Type (2027–2032)
 Table 29. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Application (2021–2026)
 Table 31. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Application (2027–2032)
 Table 33. North America Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2027–2032
 Table 48. Bio-Techne Company Details
 Table 49. Bio-Techne Business Overview
 Table 50. Bio-Techne Extracellular Vesicles Based Liquid Biopsy Product
 Table 51. Bio-Techne Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 52. Bio-Techne Recent Development
 Table 53. Thermo Fisher Scientific Company Details
 Table 54. Thermo Fisher Scientific Business Overview
 Table 55. Thermo Fisher Scientific Extracellular Vesicles Based Liquid Biopsy Product
 Table 56. Thermo Fisher Scientific Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 57. Thermo Fisher Scientific Recent Development
 Table 58. Qiagen Company Details
 Table 59. Qiagen Business Overview
 Table 60. Qiagen Extracellular Vesicles Based Liquid Biopsy Product
 Table 61. Qiagen Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 62. Qiagen Recent Development
 Table 63. Exosome Diagnostics Company Details
 Table 64. Exosome Diagnostics Business Overview
 Table 65. Exosome Diagnostics Extracellular Vesicles Based Liquid Biopsy Product
 Table 66. Exosome Diagnostics Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 67. Exosome Diagnostics Recent Development
 Table 68. Aethlon Medical Company Details
 Table 69. Aethlon Medical Business Overview
 Table 70. Aethlon Medical Extracellular Vesicles Based Liquid Biopsy Product
 Table 71. Aethlon Medical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 72. Aethlon Medical Recent Development
 Table 73. System Biosciences Company Details
 Table 74. System Biosciences Business Overview
 Table 75. System Biosciences Extracellular Vesicles Based Liquid Biopsy Product
 Table 76. System Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 77. System Biosciences Recent Development
 Table 78. NanoSomix Company Details
 Table 79. NanoSomix Business Overview
 Table 80. NanoSomix Extracellular Vesicles Based Liquid Biopsy Product
 Table 81. NanoSomix Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 82. NanoSomix Recent Development
 Table 83. Norgen Biotek Company Details
 Table 84. Norgen Biotek Business Overview
 Table 85. Norgen Biotek Extracellular Vesicles Based Liquid Biopsy Product
 Table 86. Norgen Biotek Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 87. Norgen Biotek Recent Development
 Table 88. Hitachi Chemical Company Details
 Table 89. Hitachi Chemical Business Overview
 Table 90. Hitachi Chemical Extracellular Vesicles Based Liquid Biopsy Product
 Table 91. Hitachi Chemical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 92. Hitachi Chemical Recent Development
 Table 93. Lonza Group Company Details
 Table 94. Lonza Group Business Overview
 Table 95. Lonza Group Extracellular Vesicles Based Liquid Biopsy Product
 Table 96. Lonza Group Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 97. Lonza Group Recent Development
 Table 98. Stemcell Technologies Company Details
 Table 99. Stemcell Technologies Business Overview
 Table 100. Stemcell Technologies Extracellular Vesicles Based Liquid Biopsy Product
 Table 101. Stemcell Technologies Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 102. Stemcell Technologies Recent Development
 Table 103. Aruna Bio Company Details
 Table 104. Aruna Bio Business Overview
 Table 105. Aruna Bio Extracellular Vesicles Based Liquid Biopsy Product
 Table 106. Aruna Bio Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 107. Aruna Bio Recent Development
 Table 108. Evomic Science Company Details
 Table 109. Evomic Science Business Overview
 Table 110. Evomic Science Extracellular Vesicles Based Liquid Biopsy Product
 Table 111. Evomic Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 112. Evomic Science Recent Development
 Table 113. Izon Science Company Details
 Table 114. Izon Science Business Overview
 Table 115. Izon Science Extracellular Vesicles Based Liquid Biopsy Product
 Table 116. Izon Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 117. Izon Science Recent Development
 Table 118. Exovita Biosciences Company Details
 Table 119. Exovita Biosciences Business Overview
 Table 120. Exovita Biosciences Extracellular Vesicles Based Liquid Biopsy Product
 Table 121. Exovita Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
 Table 122. Exovita Biosciences Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Extracellular Vesicles Based Liquid Biopsy Picture
 Figure 2. Global Extracellular Vesicles Based Liquid Biopsy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Type: 2025 vs 2032
 Figure 4. Blood-derived Liquid Biopsy Features
 Figure 5. Urine-derived Liquid Biopsy Features
 Figure 6. Saliva-derived Liquid Biopsy Features
 Figure 7. Other Features
 Figure 8. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Application: 2025 vs 2032
 Figure 10. Therapeutic Monitoring Case Studies
 Figure 11. Medical Diagnostics Case Studies
 Figure 12. Biological Research Case Studies
 Figure 13. Other Case Studies
 Figure 14. Extracellular Vesicles Based Liquid Biopsy Report Years Considered
 Figure 15. Global Extracellular Vesicles Based Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 16. Global Extracellular Vesicles Based Liquid Biopsy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region: 2025 vs 2032
 Figure 18. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Players in 2025
 Figure 19. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Extracellular Vesicles Based Liquid Biopsy Revenue in 2025
 Figure 21. North America Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. North America Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2021–2032)
 Figure 23. United States Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Canada Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2021–2032)
 Figure 27. Germany Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. France Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. U.K. Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Italy Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Russia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Ireland Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2021–2032)
 Figure 35. China Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Japan Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. South Korea Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Southeast Asia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. India Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Australia & New Zealand Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2021–2032)
 Figure 43. Mexico Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Brazil Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2021–2032)
 Figure 47. Israel Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. UAE Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Bio-Techne Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 52. Qiagen Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 53. Exosome Diagnostics Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 54. Aethlon Medical Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 55. System Biosciences Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 56. NanoSomix Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 57. Norgen Biotek Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 58. Hitachi Chemical Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 59. Lonza Group Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 60. Stemcell Technologies Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 61. Aruna Bio Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 62. Evomic Science Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 63. Izon Science Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 64. Exovita Biosciences Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona